| Tag | Content |
|---|
EnhancerAtlas ID | HS139-25231 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr18:51796030-51797720 |
Target genes | |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxd3 | MA0041.1 | chr18:51797316-51797328 | GTTTGTTTGTTT | + | 6.32 | | HES2 | MA0616.2 | chr18:51796677-51796687 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr18:51796677-51796687 | GGCACGTGCC | - | 6.02 | | MEF2A | MA0052.3 | chr18:51797250-51797262 | GCTAAAAATAGC | + | 6.44 | | MEF2B | MA0660.1 | chr18:51797250-51797262 | GCTAAAAATAGC | + | 6.92 | | MEF2C | MA0497.1 | chr18:51797248-51797263 | GAGCTAAAAATAGCC | + | 6.83 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_58972 | chr18:51772671-51812936 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr18 | 51797168 | 51797291 | | chr18 | 51797589 | 51797663 |
|
Enhancer Sequence | GGTGCGCCGC AGCCAGAGGA GCCAGCGGCC TCCTTGGGTG TAAATGAGAA GGGTGGGGCA 60
GGCGGACGCT CGGGGCGGCG GCCACTGGGG CGCGACCGTC CCCGCCCCAC TCGGCTCCTC 120
TAAGAGAGGG CTGCCTCCCT CTGCCTTGTG TTACGCGGCG GGTACCTCTA GAGGAATGGC 180
TTCACCCAGC AGGAGTAGGG TGGGGCGCGT CCACACTACA AATACGTGTC GAGGGTTTAT 240
CTGCGCCGTC CTTTCCTCTG TGAGGGGCGA GGTGGGGCGG GAATCCCTCA GCCAGCCCGA 300
CGAAAACTGC AGAGGCTTCT GGGCCTTTTA ACTTTGGAGA AGTTGAGGAC CTTGTCGCTC 360
ATTTGGCAGA AGGTGGGACC CGGATCTCAG TCCTGGCAGG AAGGGATGGC TCAGAACCTA 420
GGCGGAGTCA GGTCCGCTGT GGTCACGTCT CCGGTGACCC ACTTCCAGCT CTGGTCTTTA 480
CCTTGTACCG CCCACCTCAG GGCCTGGATG TAAAGGCACC GGTTCTCATT TCCTGCTGGT 540
TTTGTTTCAT TCATTAATTT AGAGACAAGG TCTCCCTGCA GCCTCGAACC CCTGGGCTCA 600
AGTGATCCTC CGCCCCAGCC TCTCCGTCCC GAGTAGCTGG GACAGCAGGC ACGTGCCACC 660
ACACCTGGCT GATTTTCAGA TTTTTTTAGA TCAGGTGTAG CTGTGTTGTC CAGGCTGGTC 720
TCAAACTCCA GCCACAAGCG ATCCTTCCAC CTCAGCTTCG AAAAGTATTG GGATTACAGT 780
AGTTAGCCAT CGTGCCTGGC CTTTTAAATT TTGGAACTTT AGGTTTACCT GAAAGTTGCA 840
GAGCTAGATC CCCCTAGTGT TAACATAAAC TCAGTACATT TGTCAAAACT AGGAAATTAA 900
CATTGGTATA ATACTATTAA TTGAACTACA CGCTTTATTA ATATTCTACC AGTTTTTCTG 960
CTAACGTTCA TTTTCTGTTC CAGGATCCCA ACCAGAATAT TGTATTGTAT TTTGCCTGTC 1020
TTGTTTTTAG CCAGTGTTGA GAGAAGGAGT CGCCTCTGTC ATTCCCTCCC CGACAAATAA 1080
TGACCTAACA ACTTTTTAAA ATCAAAGAAC TATTCAGTCT TTCAATTTAG TGAATATTTA 1140
TTGGTGGTCT GTTATGTCCT AGACACTGTT TTAGGCACTG GCGATTTAGC ATTAAACCAG 1200
ATAATCCTGC TGCCATGGGA GCTAAAAATA GCCCACACTT GTACCCACTG GTTGTCTTTT 1260
GCCATTTTGT ATTTCAGTTT TTGTTGGTTT GTTTGTTTTA AATGTAAGGG CATGCTGCTT 1320
AGAATAATTT TCAAGCTGTG TGAAAATCAA CGTCATTTCA ACTTTTCTGC CCCTTCTGGT 1380
TTACACTAAG AGCTACTATA AACTTCCAGG TGATAGTATT AGCTCTTTCA TCATCCATTA 1440
TTTATCACAT TTTTTCCCTT CAAACTTATT ACTATCCTGA GAAAAACGCA GTGCACAAAC 1500
AGTAATTAAG AGGACTGAAG ACCCTACCCT AAGTGGAGTT TCATGTCTTT GTAATTTTTC 1560
GATGCTTTCA CACATAATCC AGGAGAAAAC ACGTCACTCT GCATTCTTCC TTCACAGGTA 1620
CCATGTTTTA AGGAACTGTC AGTTGCTCAG AGATAATAAG CAGCCTGAAT TTCTTTTTAT 1680
TTCTTTGCAT 1690
|
